Developer docs
API playgroundTry for free, no card

Search company profiles

1mg

Full company profile

uuid00039eq

Namestring
1mg
Legal namestring
TATA 1mg Healthcare Solutions Pvt. Ltd.
Websiteurl
1mg.com
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersGurugram, India
HQ citystring
Gurugram
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
online pharmacy services, diagnostic testing platform, telemedicine consultations, healthcare marketplace, medicine delivery network
Industry3 codes
1Medical, Dental & Lab Supply Marketplaces
CodeCRAFAHAGPrimaryYes
2Specialty Pharmacy & Complex Therapy Management Platforms
CodeHLACAKAGPrimaryNo
3Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
CodeHLALAAADPrimaryNo
NAICS code2 codes
  • Pharmacies and Drug Retailers456110
  • Medical and Diagnostic Laboratories62151
SIC code3 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Services-Misc Health & Allied Services, Nec8090
Product category
Online Pharmacy & Digital Healthcare
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Medicine Sales
TypeTransaction Fee
Description

Online sale of prescription and OTC medicines with margins of 10-25% on products sold.

miracuves.com
2Diagnostic Lab Commissions
TypeTransaction Fee
Description

Commission-based revenue from partnerships with 2,500+ diagnostic labs for sample collection and testing services, with commissions of 20-30%.

miracuves.com
3Doctor Consultation Fees
TypeTransaction Fee
Description

Telemedicine consultations with doctors at fees ranging from ₹100-₹500 per session.

miracuves.com
4Care Plan Subscriptions
TypeSubscription Recurring
Description

Monthly subscription service (Care Plan) starting at ₹99/month providing discounts and benefits on medicines and health products.

miracuves.com
5Pharmaceutical Advertising
TypeAdvertising
Description

Advertising services for pharmaceutical companies and health product brands on the platform.

miracuves.com
6B2B Corporate Health Services
TypeProfessional Services
Description

Corporate wellness programs and employee health benefits packages sold to enterprise customers.

miracuves.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details4 tiers
1Care Plan subscription offering platform-wide discounts on medicines and health products
ModelSubscriptionBilling cadenceMonthly
Notes

Starting at ₹99/month for Care Plan subscription providing discounts on medicines and health products

miracuves.com
2Doctor consultation fees
ModelPer seatBilling cadencePay-as-you-go
Notes

Doctor consultation fees range from ₹100-₹500 per session

miracuves.com
3Lab test packages with discounts up to 70%
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Full body checkup packages ranging from ₹499 to ₹4,999 with up to 70% off; individual tests like CBC from ₹319, Lipid Profile from ₹399

4Over-the-counter health products and supplements
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Wide range of OTC products including supplements, personal care, and wellness products with various price points

miracuves.com
GTM typeB2B and B2C
B2B and B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

1mg (Tata 1mg) operates a full-stack digital healthcare platform combining an online pharmacy (prescription and OTC medicine sales with 10-25% margins), diagnostic lab services through Tata 1mg Labs, and online doctor consultations (₹100-₹500 per session). The platform distributes medicines, diagnostics, and consultations via its website and mobile app across 1,000+ cities in India, with same-day and 40-minute quick commerce delivery in major metros, and adds a subscription Care Plan and B2B corporate wellness programs on top.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 40% of quick commerce orders delivered within 30 minutes
+3 more records
Product overview1 text field

1mg (operated as Tata 1mg) is a full-stack digital healthcare platform under Tata Digital, functioning as a multi-category health marketplace and services aggregator. The core offering comprises an online pharmacy (medicine sales with 10-25% margins) integrated with Tata 1mg Labs for diagnostic testing (offering tests from basic blood work to comprehensive full-body checkups with 20-30% lab commissions), and online doctor consultations (₹100-₹500 per session). The platform extends into specialized verticals including Cancer Care, Ayurveda, and Homeopathy product categories, alongside a private label brand (Tata 1mg Tejasya) covering supplements, pain relief devices, and personal care products. A subscription-based Care Plan (starting at ₹99/month) drives recurring revenue, while Corporate Wellness services address B2B employer health benefits. The platform has evolved from a classifieds model to an inventory-led quick commerce operation achieving 40% of orders within 30 minutes in major cities, with delivery coverage across 1,000+ Indian cities and partnerships with 2,500+ diagnostic labs. Revenue is generated through medicine sales, diagnostic commissions, consultation fees, pharmaceutical advertising, Care Plan subscriptions, and B2B corporate health services.

Product and service1 record
1Medicines (Online Pharmacy)
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-13
Description

Tata 1mg is expanding into full-stack healthcare ecosystem by integrating online and offline services, leveraging cross-brand synergies within Tata Group for multi-category quick commerce.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Extensive network of diagnostic lab partners providing pathology testing services. Labs offer sample collection at patient homes and process tests with commissions of 20-30% paid to 1mg.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Tata Group sister company enabling pharmacy delivery through existing dark store infrastructure. Pharmacy service live across 40 locations in Bengaluru, Hyderabad, and Chennai, leveraging BigBasket's quick commerce capabilities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Tata brand electronics retailer integrated into multi-category quick commerce offering through BigBasket platform.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Tata food delivery brand being integrated into multi-category quick commerce expansion through dark store network.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Tata brand included in multi-category quick commerce expansion plans through dark store distribution.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

PharmEasy is one of India's largest online pharmacy and diagnostic platforms, offering medicine delivery, lab test bookings, and teleconsultations. It is the most direct competitor to Tata 1mg in the Indian e-pharmacy space, with a comparable full-stack model including own diagnostics (Thyrocare acquisition) and aggressive discounting.

TypeDirect peer
Description

Apollo 24/7 is the digital healthcare arm of Apollo Hospitals, offering online pharmacy, diagnostic tests, and doctor consultations. It is a directly comparable full-stack digital health platform leveraging a strong hospital brand, similar to Tata 1mg's Tata Group backing.

TypeDirect peer
Description

Netmeds is an online pharmacy platform acquired by Reliance Industries. It directly competes with Tata 1mg in medicine delivery, diagnostics, and teleconsultations across India, with similar subscription and quick delivery models.

TypeDirect peer
Description

Flipkart Health+ is the e-pharmacy venture of Flipkart/Walmart, offering online medicine delivery and diagnostics. It is a direct competitor leveraging Flipkart's consumer reach, logistics infrastructure, and aggressive pricing to challenge Tata 1mg.

TypeBroad incumbent
Description

Amazon Pharmacy is the global e-commerce giant's online pharmacy offering in India, providing prescription and OTC medicine delivery. As a global incumbent with deep capital and logistics infrastructure, it represents a significant competitive threat to Tata 1mg's e-pharmacy business.

TypeDirect peer
Description

Practo is an Indian digital healthcare platform focused on doctor consultations, clinic management, and diagnostic bookings. It directly overlaps with Tata 1mg's telemedicine and diagnostics verticals, though less focused on pharmacy fulfillment.

TypeDirect peer
Description

MedPlus is one of India's largest pharmacy retail chains with an online medicine delivery platform. It competes with Tata 1mg on both physical pharmacy presence and online medicine delivery, leveraging its nationwide store network.

TypeEmerging player
Description

Blinkit, owned by Zomato, is a leading quick commerce platform in India that has expanded into medicine delivery. It competes with Tata 1mg's quick commerce offering through its established dark store network and 10-15 minute delivery promise.

TypeEmerging player
Description

Swiggy Instamart is the quick commerce arm of Swiggy, offering rapid delivery of groceries and increasingly medicines. It is an emerging competitor to Tata 1mg's quick commerce pharmacy delivery, leveraging Swiggy's existing logistics infrastructure.

TypeEmerging player
Description

Zepto is an Indian quick commerce startup promising 10-minute delivery. While primarily focused on groceries, it has been expanding into pharmacy and health products, representing an emerging competitive threat to Tata 1mg's quick commerce medicine delivery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds15 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors19 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

1mg

Online Pharmacy & Digital Healthcare1mg.com

1mg firmographics

Firmographics
Name
1mg
Legal name
TATA 1mg Healthcare Solutions Pvt. Ltd.
Website
https://1mg.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

1mg industry classification

Industry
Product category
Online Pharmacy & Digital Healthcare
NAICS
Pharmacies and Drug Retailers (456110), Medical and Diagnostic Laboratories (62151)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)
akta.pro secondary industries
Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

Keywords

  • Online pharmacy services
  • Diagnostic testing platform
  • Telemedicine consultations
  • Healthcare marketplace
  • Medicine delivery network

Where 1mg is headquartered

Location

Headquarters

HQ city
Gurugram
HQ country
India
HQ region
Asia

Offices1 record

Markets served

1mg business model

Business model
GTM type
B2B and B2C
Offering type
Digital Commerce or Content
Cost components
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Medicine Sales: Online sale of prescription and OTC medicines with margins of 10-25% on products sold.
  2. Diagnostic Lab Commissions: Commission-based revenue from partnerships with 2,500+ diagnostic labs for sample collection and testing services, with commissions of 20-30%.
  3. Doctor Consultation Fees: Telemedicine consultations with doctors at fees ranging from ₹100-₹500 per session.
  4. Care Plan Subscriptions: Monthly subscription service (Care Plan) starting at ₹99/month providing discounts and benefits on medicines and health products.
  5. Pharmaceutical Advertising: Advertising services for pharmaceutical companies and health product brands on the platform.
  6. B2B Corporate Health Services: Corporate wellness programs and employee health benefits packages sold to enterprise customers.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyCare Plan subscription offering platform-wide discounts on medicines and health products
Per seatPay-as-you-goDoctor consultation fees
Unit PricingPay-as-you-goLab test packages with discounts up to 70%
Unit PricingPay-as-you-goOver-the-counter health products and supplements

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

1mg product offering

Product offering

Core offering

1mg (Tata 1mg) operates a full-stack digital healthcare platform combining an online pharmacy (prescription and OTC medicine sales with 10-25% margins), diagnostic lab services through Tata 1mg Labs, and online doctor consultations (₹100-₹500 per session). The platform distributes medicines, diagnostics, and consultations via its website and mobile app across 1,000+ cities in India, with same-day and 40-minute quick commerce delivery in major metros, and adds a subscription Care Plan and B2B corporate wellness programs on top.

Product overview

1mg (operated as Tata 1mg) is a full-stack digital healthcare platform under Tata Digital, functioning as a multi-category health marketplace and services aggregator. The core offering comprises an online pharmacy (medicine sales with 10-25% margins) integrated with Tata 1mg Labs for diagnostic testing (offering tests from basic blood work to comprehensive full-body checkups with 20-30% lab commissions), and online doctor consultations (₹100-₹500 per session). The platform extends into specialized verticals including Cancer Care, Ayurveda, and Homeopathy product categories, alongside a private label brand (Tata 1mg Tejasya) covering supplements, pain relief devices, and personal care products. A subscription-based Care Plan (starting at ₹99/month) drives recurring revenue, while Corporate Wellness services address B2B employer health benefits. The platform has evolved from a classifieds model to an inventory-led quick commerce operation achieving 40% of orders within 30 minutes in major cities, with delivery coverage across 1,000+ Indian cities and partnerships with 2,500+ diagnostic labs. Revenue is generated through medicine sales, diagnostic commissions, consultation fees, pharmaceutical advertising, Care Plan subscriptions, and B2B corporate health services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medicines (Online Pharmacy)

Quantifiable outcome

  • 40% of quick commerce orders delivered within 30 minutes
  • +3 more outcomes

Companies that use 1mg

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

1mg technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

1mg partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Tata Group CompaniescoreStrategic or Co-development Partner · 13 October 2025Tata 1mg is expanding into full-stack healthcare ecosystem by integrating online and offline services, leveraging cross-brand synergies within Tata Group for multi-category quick commerce.
  • Diagnostic Laboratories (2,500+)coreStrategic or Co-development PartnerExtensive network of diagnostic lab partners providing pathology testing services. Labs offer sample collection at patient homes and process tests with commissions of 20-30% paid to 1mg.
  • BigBasketcoreStrategic or Co-development PartnerTata Group sister company enabling pharmacy delivery through existing dark store infrastructure. Pharmacy service live across 40 locations in Bengaluru, Hyderabad, and Chennai, leveraging BigBasket's quick commerce capabilities.
  • CromaminorStrategic or Co-development PartnerTata brand electronics retailer integrated into multi-category quick commerce offering through BigBasket platform.
  • QminminorStrategic or Co-development PartnerTata food delivery brand being integrated into multi-category quick commerce expansion through dark store network.
  • Starbucks (Tata Starbucks)minorStrategic or Co-development PartnerTata brand included in multi-category quick commerce expansion plans through dark store distribution.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

1mg competitors and assessment

Company assessment

Direct peers

  • PharmEasy: PharmEasy is one of India's largest online pharmacy and diagnostic platforms, offering medicine delivery, lab test bookings, and teleconsultations. It is the most direct competitor to Tata 1mg in the Indian e-pharmacy space, with a comparable full-stack model including own diagnostics (Thyrocare acquisition) and aggressive discounting.
  • Apollo 24/7: Apollo 24/7 is the digital healthcare arm of Apollo Hospitals, offering online pharmacy, diagnostic tests, and doctor consultations. It is a directly comparable full-stack digital health platform leveraging a strong hospital brand, similar to Tata 1mg's Tata Group backing.
  • Netmeds: Netmeds is an online pharmacy platform acquired by Reliance Industries. It directly competes with Tata 1mg in medicine delivery, diagnostics, and teleconsultations across India, with similar subscription and quick delivery models.
  • Flipkart Health+: Flipkart Health+ is the e-pharmacy venture of Flipkart/Walmart, offering online medicine delivery and diagnostics. It is a direct competitor leveraging Flipkart's consumer reach, logistics infrastructure, and aggressive pricing to challenge Tata 1mg.
  • Practo: Practo is an Indian digital healthcare platform focused on doctor consultations, clinic management, and diagnostic bookings. It directly overlaps with Tata 1mg's telemedicine and diagnostics verticals, though less focused on pharmacy fulfillment.
  • MedPlus: MedPlus is one of India's largest pharmacy retail chains with an online medicine delivery platform. It competes with Tata 1mg on both physical pharmacy presence and online medicine delivery, leveraging its nationwide store network.

Broad incumbents

  • Amazon Pharmacy (India): Amazon Pharmacy is the global e-commerce giant's online pharmacy offering in India, providing prescription and OTC medicine delivery. As a global incumbent with deep capital and logistics infrastructure, it represents a significant competitive threat to Tata 1mg's e-pharmacy business.

Emerging players

  • Blinkit (Zomato): Blinkit, owned by Zomato, is a leading quick commerce platform in India that has expanded into medicine delivery. It competes with Tata 1mg's quick commerce offering through its established dark store network and 10-15 minute delivery promise.
  • Swiggy Instamart: Swiggy Instamart is the quick commerce arm of Swiggy, offering rapid delivery of groceries and increasingly medicines. It is an emerging competitor to Tata 1mg's quick commerce pharmacy delivery, leveraging Swiggy's existing logistics infrastructure.
  • Zepto: Zepto is an Indian quick commerce startup promising 10-minute delivery. While primarily focused on groceries, it has been expanding into pharmacy and health products, representing an emerging competitive threat to Tata 1mg's quick commerce medicine delivery.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

1mg social profiles

Digital presence

1mg financial estimates

Financial estimate

Revenue estimate

Valuation estimate

1mg leadership team

Management profile

Number of profiles

Profiles4 records

1mg subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

1mg funding detail

Funding detail

Funding overview

Funding rounds15 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

1mg M&A and investment

M&A and investment

M&A3 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 1mg

What does 1mg do?

1mg (Tata 1mg) operates a full-stack digital healthcare platform combining an online pharmacy (prescription and OTC medicine sales with 10-25% margins), diagnostic lab services through Tata 1mg Labs, and online doctor consultations (₹100-₹500 per session). The platform distributes medicines, diagnostics, and consultations via its website and mobile app across 1,000+ cities in India, with same-day and 40-minute quick commerce delivery in major metros, and adds a subscription Care Plan and B2B corporate wellness programs on top.

Is 1mg a public or private company?

1mg is a private company. It is classified as corporate owned and is currently operating.

When was 1mg founded?

1mg was founded in 2015. It employs 1,001 to 5,000 people.

Where is 1mg based?

1mg is headquartered in Gurugram, India, in the Asia region.

How does 1mg make money?

Six revenue lines are on record. Medicine Sales are the primary driver. The others are diagnostic Lab Commissions, doctor Consultation Fees, care Plan Subscriptions, pharmaceutical Advertising and B2B Corporate Health Services.

Who are 1mg's main competitors?

Direct peers on record are PharmEasy, Apollo 24/7, Netmeds, Flipkart Health+, Practo and MedPlus. Amazon Pharmacy (India) is listed as a broad incumbent. Emerging players are Blinkit (Zomato), Swiggy Instamart and Zepto.

Does 1mg have an API?

No public API is recorded for 1mg.

What industry is 1mg in?

1mg's product category is Online Pharmacy & Digital Healthcare. Its primary akta.pro industry code is CRAFAHAG, Medical, Dental & Lab Supply Marketplaces, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 456110 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EntrackrTata 1mg revenue nears Rs 3,000 Cr in FY26; loss narrows to Rs 287 CrTata 1mg's consolidated revenue grew 23% to Rs 2,936 crore in FY26, while its net loss narrowed to Rs 287 crore. The loss came from Tata 1mg Healthcare Solutions, which posted a Rs 310 crore loss, offset by a Rs 23 crore profit from Tata 1mg Technologies.IjpsjournalRise of E-Pharmacies in India: A Case Study on Growth, Operational Models, Regulatory Framework, and Future ProspectsThis academic case study examines the rise of e-pharmacies in India over the past decade, tracing their evolution from early price-comparison portals in 2013 to a multi-billion-dollar sector projected to grow at a compound annual growth rate of 18–20% through 2028. The report identifies five major platforms—PharmEasy, 1mg, Netmeds, Apollo Pharmacy, and MedPlus—each pursuing distinct operational models including marketplace, inventory-holding, hybrid (phygital), and subscription-based approaches, with notable consolidation driven by acquisitions from Tata Digital (1mg) and Reliance Retail (Netmeds). The study highlights critical unresolved challenges including inconsistent prescription verification, counterfeit medicine risks, cold chain limitations, data privacy concerns, and the absence of finalized regulatory framework under the draft Online Pharmacy Rules pending since 2018.The Economic TimesMedicine delivery enters quick lane but roadblocks remainQuick commerce companies and startups are aggressively expanding rapid medicine delivery services across India, with firms like 1mg achieving 40% of orders within 30 minutes and Apollo 24/7 delivering 60% of orders in 19 minutes in major cities. Industry executives warn that scaling these services faces significant hurdles including capital-intensive physical pharmacy store requirements, complex regulatory compliance around scheduled medicines, and dispensation error risks. Major quick commerce players including Tata Digital-backed 1mg, Apollo 24/7, Swiggy Instamart, Flipkart Minutes, Zepto, and Pharmeasy are competing for market share in this emerging segment.Markhub24Tata 1mg:Trust-Based Brand Strategy in Health-TechTata Digital Ltd., a subsidiary of Tata Sons, acquired approximately 60% stake in 1MG Technologies Private Limited in June 2021 for $220–240 million, integrating the e-pharmacy and diagnostics platform under the Tata Group umbrella. Tata 1mg pursued a trust-led brand differentiation strategy, deploying multi-layered trust signals including NABL-accredited diagnostics labs, a certified supply chain, and campaigns like 'Trust What You See' to position against price-focused competitors. The strategy yielded measurable results: India's e-pharmacy GMV market share grew from 19% in October 2022 to 31% by September 2023, overtaking PharmEasy, while revenue expanded from ₹134 crore in FY21 to ₹1,968 crore by FY24.IndiaWeb2Tata Digital Shake-Up: BigBasket and 1mg Founders Step Back as New Leadership Takes OverTata Digital is undergoing a major leadership reset with BigBasket co-founders Hari Menon and Vipul Parekh in final stages of exiting operational roles, while 1mg founders Prashant Tandon and Gaurav Agarwal are reassessing their positions after five years with the company. The exits signal a decisive shift toward professionalized management under CEO Sajith Sivanandan, who is driving a profitability-first reset amid intensifying competition in quick commerce from Blinkit, Zepto, and Swiggy Instamart. Uncertainty over IPO timelines and shareholder exit paths remain key concerns for both subsidiaries.The Times of IndiaNoel Tata lists out criteria on which Chandra must deliverTata Trusts chairman Noel Tata presented performance criteria at a Tata Sons board meeting that Natarajan Chandrasekaran must meet for his chairmanship extension to be approved, including turning around loss-making aviation and digital services, managing heavy capital expenditure in semiconductors and batteries, and maintaining the company's unlisted status. The extension, initially passed by Tata Trusts last July, is now facing renewed scrutiny with Noel Tata exercising the veto right that Tata Trusts nominees hold on the board. Tata Digital, set up five years ago and which bought Bigbasket and 1mg, made the second-highest loss of Rs 4,610 crore in the group, while the combined market capitalisation of 24 Tata group companies has fallen by Rs 3 lakh crore or 12.5% over the last year.UpgrowthProvider vs Aggregator: Who AI Cites for HealthcareThe 2026 Surfer AI Citation Report analyzed over 36 million AI Overviews and found that AI platforms cite health content aggregators and government institutions over individual hospitals by a significant margin, with NIH commanding approximately 39% of health citations and Healthline capturing around 15%, while individual hospitals, specialty clinics, and healthtech platforms barely register in AI responses. In India's healthcare market specifically, Practo, 1mg, and PharmEasy appear in 70-85% of AI responses for provider-related queries, despite aggregators often having less specialized clinical expertise than the hospitals they replace in AI-generated answers. The report outlines structural advantages aggregators possess, including comprehensive coverage at scale, structured data implementation, and high update frequency, and provides strategic guidance for healthcare providers to build AI citation authority within a closing window of opportunity.Supreme Court NewsDark Patterns And Deep Manipulation: Regulating Psychological Exploitation In Indian Digital MarketsThis article examines dark patterns—deceptive user-interface designs that manipulate consumer behavior—and analyzes how India's legal framework, including the Consumer Protection Act 2019, CCPA draft guidelines, and DPDP Act 2023, addresses these practices alongside international regulatory approaches. On May 28, 2025, India's Consumer Affairs Minister held a high-level meeting with major e-commerce and technology platforms including Amazon, Flipkart, 1mg, and Meta to address dark-pattern concerns, coinciding with initiatives such as the Dark Patterns Buster Hackathon with IIT-BHU. The piece emphasizes that India's multi-layered regulatory strategy prohibits deceptive UI designs, mandates transparent consent and pricing, and embeds stringent data protection requirements, with international regulators similarly converging on safeguards for autonomy in online interfaces.The Times of IndiaAayush Wellness Launches Brain Fuel Capsules to Enhance Memory and Cognitive Function, ETRetailTata 1mg is planning a $300 million external funding round to support offline expansion and new initiatives. The e-pharmacy firm, which raised $40 million since its 2021 Tata Digital stake, expects FY2025 revenue to grow 30-35% to Rs 2,500-2,600 crore. It is setting up offline stores for 30-minute deliveries in several cities.MiracuvesBusiness Model of 1mg: How the Platform Earns RevenueThis article provides an analytical overview of 1mg's business model, describing it as India's largest digital healthcare platform combining e-pharmacy, diagnostics, and teleconsultation services into a unified ecosystem. The platform generates revenue through multiple streams including medicine sales, diagnostic test commissions, teleconsultation fees, subscription programs, and sponsored content from pharmaceutical brands. The article targets entrepreneurs and startup founders interested in building similar health-tech platforms, offering operational insights into costs, revenue diversification strategies, and compliance requirements within India's digital healthcare landscape.